Psychiatry

    Douglas A. Bigelow, Ph.D.

    Research Projects:
    Ongoing or completed during the last 3 years

  1. "Factors in the distribution of psychiatrists and psychiatric services in British Columbia; Services received by persons with psychiatric diagnoses in British Columbia; A plan for serving persistently and seriously mentally ill persons in British Columbia". Agency: Ministry of Health and Ministry Responsible for Seniors, Province of British Columbia, Canada.
    Develops information from a province-wide client-and-provider data base upon which to base a plan for re-organizing mental health services, especially reconfiguration and wider dispersal of secure and intensive care services. (Principal Investigator)

  2. "Alcohol abuse in urban Indian adolescents and women. Agency: National Institute on Alcoholism and Alcohol Abuse". Type: AA 07103 11 (09/01/98-01/31/00). Principal Investigator: R. Dale Walker, M.D. Prospective epidemiological study of incidence, prevalence, acquisition curve, and risk factors for substance abuse in a population of American Indians. (Co-investigator)

  3. "Seriously mentally ill Medicaid clients in rural Oregon." Agency: SAMHSA.Type: UR7 TI11315-0. Principal Investigator: Bentson H. McFarland, M.D., Ph.D. Compares utilization, satisfaction, and outcomes of fee for service versus capitated mental health programs for Oregon Medicaid clients with serious mental disorders. (Co-investigator)

  4. "Capitated Medicaid for clients with alcohol problems." Agency: NIAAA. Type: 1 R01 A11 770-01. Principal Investigator: Bentson H. McFarland, M.D., Ph.D. Examines the impact of capitated payment on services to, and outcomes for, substance abusing clients, especially those with dual diagnoses. (Co-investigator)

  5. "Managed care and Medicaid drug abuse treatment services." Agency: NIDA. Type: R01 DA11970. Principal Investigator: Bentson H. McFarland, M.D., Ph.D. Examines the impact of organizational factors (i.e., integrated within health maintenance organizations versus “carved-out” behavioral health programs) on services for Medicaid clients with drug abuse problems. (Co-investigator)

  6. "Dual diagnosis policy and planning for state services. Agency: State Department of Human Services." Principal: R. Dale Walker, MD. Develops policy and planning recommendations through consensus process and research literature. (Co-investigator)

  7. "National clinical trials network." Agency: NIDA. Type: 1 U10 DA 13036-01. Principal Investigator: Merwyn R. Greenlick, Ph.D. Phase IV, multi-site trial of drug treatment protocols; develop collaboration of research and practice. (Co-investigator)

  8. "Effectiveness of atypical antipsychotics for difficult-to-serve clients." Agency: Oregon State Office for Mental Health Services. Phase IV study of impact on symptom severity, function, service utilization, and costs of use of atypicals. (Principal Investigator)

  9. "Urban American Indian Practice/Research Collaborative" Agency: SAMHSA. TI 12255. Principal Investigator: R. Dale Walker, M.D. Develops collaboration of research and practice. (Co-investigator)

  10. "Drug Courts and Medicaid Managed Behavioral Health Care" Agency: NIDA. R01 DA13091. Principal Investigator: Bentson H. McFarland, M.D., Ph.D. (Co-investigator)

  11. "fMRI Studies of Brain Metabolism Associated with Auditory, Visual, and Olfactory Stimuli. Agency: Pfizer. Principal Investigator: William H. Wilson, M.D. (Co-investigator)

  12. "Pilot Study for fMRI and Clinical Assessment of Lamotrigine Adjunctive Therapy for PTSD. Agency: GlaxoSmithKline. Principal Investigator: Thomas A. Passmore, D.O. (Co-investigator)
Faculty Page Research Projects

OHSU | Faculty | Grand Rounds | Home